Overnight offering: We are a clinical stage macrophage reprogramming immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing.
Last Closing Price
February 10, 2021
H.C. WAINWRIGHT & CO., INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Enlivex Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277